drugset / Trial / NCT03577730

Caffeine and Neurologic Recovery Following Surgery and General Anesthesia

NCT03577730

Phase 0 Completed 71 enrolled University of Michigan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The ongoing opioid epidemic is a public health crisis, and surgical patients are particularly vulnerable to opioid-dependency and related risks. Emerging data suggest that caffeine may reduce pain after surgery. Thus, the purpose of this study is to test whether caffeine reduces pain and opioid requirements after surgery. The investigators will also test whether caffeine improves mood and brain function (e.g., learning, memory) after surgery.

Timeline

Start
2018-07-10
Primary completion
2019-11-21
Completion
2020-01-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 200 mg Intravenous

Indications